Warning! GuruFocus detected
1 Severe warning sign
with APCO.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Asian Phytoceuticals PCL
NAICS : 446120
ISIN : TH1077A10Z09
Description
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 14.59 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.27 | |||||
| Interest Coverage | 33.34 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 16.81 | |||||
| Beneish M-Score | -2.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.9 | |||||
| 3-Year EBITDA Growth Rate | -7.4 | |||||
| 3-Year EPS without NRI Growth Rate | -7.7 | |||||
| 3-Year FCF Growth Rate | -24.8 | |||||
| 3-Year Book Growth Rate | -2.2 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.48 | |||||
| 9-Day RSI | 46.04 | |||||
| 14-Day RSI | 43.88 | |||||
| 3-1 Month Momentum % | -31.25 | |||||
| 6-1 Month Momentum % | -40.54 | |||||
| 12-1 Month Momentum % | -32.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.75 | |||||
| Quick Ratio | 9.28 | |||||
| Cash Ratio | 9.1 | |||||
| Days Inventory | 440.89 | |||||
| Days Sales Outstanding | 3.45 | |||||
| Days Payable | 13.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.66 | |||||
| Dividend Payout Ratio | 2.09 | |||||
| 3-Year Dividend Growth Rate | 14.5 | |||||
| Forward Dividend Yield % | 2.89 | |||||
| 5-Year Yield-on-Cost % | 7.79 | |||||
| Shareholder Yield % | 4.77 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.57 | |||||
| Operating Margin % | 25.19 | |||||
| Net Margin % | 25.95 | |||||
| FCF Margin % | 16.77 | |||||
| ROE % | 9.54 | |||||
| ROA % | 8.27 | |||||
| ROIC % | 12.65 | |||||
| 3-Year ROIIC % | 6.96 | |||||
| ROC (Joel Greenblatt) % | 71.24 | |||||
| ROCE % | 11.25 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 35.38 | |||||
| PE Ratio without NRI | 37.44 | |||||
| Shiller PE Ratio | 18.73 | |||||
| Price-to-Owner-Earnings | 34.84 | |||||
| PEG Ratio | 11.35 | |||||
| PS Ratio | 9.14 | |||||
| PB Ratio | 3.47 | |||||
| Price-to-Tangible-Book | 3.46 | |||||
| Price-to-Free-Cash-Flow | 54.58 | |||||
| Price-to-Operating-Cash-Flow | 51.11 | |||||
| EV-to-EBIT | 23.1 | |||||
| EV-to-EBITDA | 17.81 | |||||
| EV-to-Revenue | 7.62 | |||||
| EV-to-FCF | 45.8 | |||||
| Price-to-GF-Value | 0.73 | |||||
| Price-to-Projected-FCF | 1.56 | |||||
| Price-to-Median-PS-Value | 0.88 | |||||
| Price-to-Graham-Number | 2.4 | |||||
| Price-to-Net-Current-Asset-Value | 5.75 | |||||
| Price-to-Net-Cash | 7.16 | |||||
| Earnings Yield (Greenblatt) % | 4.33 | |||||
| FCF Yield % | 1.83 | |||||
| Forward Rate of Return (Yacktman) % | 9.32 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Asian Phytoceuticals PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 210.83 | ||
| EPS (TTM) (฿) | 0.091 | ||
| Beta | 0.63 | ||
| 3-Year Sharpe Ratio | -0.3 | ||
| 3-Year Sortino Ratio | -0.44 | ||
| Volatility % | 55.94 | ||
| 14-Day RSI | 43.88 | ||
| 14-Day ATR (฿) | 0.103368 | ||
| 20-Day SMA (฿) | 3.265 | ||
| 12-1 Month Momentum % | -32.1 | ||
| 52-Week Range (฿) | 2.5 - 8.35 | ||
| Shares Outstanding (Mil) | 600 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Asian Phytoceuticals PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Asian Phytoceuticals PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| No Event Data | ||||
Asian Phytoceuticals PCL Frequently Asked Questions
What is Asian Phytoceuticals PCL(BKK:APCO)'s stock price today?
The current price of BKK:APCO is ฿3.22. The 52 week high of BKK:APCO is ฿8.35 and 52 week low is ฿2.50.
When is next earnings date of Asian Phytoceuticals PCL(BKK:APCO)?
The next earnings date of Asian Phytoceuticals PCL(BKK:APCO) is .
Does Asian Phytoceuticals PCL(BKK:APCO) pay dividends? If so, how much?
The Dividend Yield %  of Asian Phytoceuticals PCL(BKK:APCO) is 5.66% (As of Today), Highest Dividend Payout Ratio of Asian Phytoceuticals PCL(BKK:APCO) was 2.12. The lowest was 0.1. And the median was 1.03. The  Forward Dividend Yield % of Asian Phytoceuticals PCL(BKK:APCO) is 2.89%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers